You are here

Inovio plans human trials for potential Covid-19 vaccine in South Korea in June

Experts predict a safe and effective vaccine could take 12 to 18 months to develop.

[SEOUL] Inovio Pharmaceuticals said on Thursday it plans to begin early human trials of its experimental Covid-19 vaccine in South Korea later in June and partnered with non-profit organisation International Vaccine Institute.

The company said the two-stage trial, conducted in...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to